Breaking Down HOOKIPA Pharma: 4 Analysts Share Their Views
Breaking Down HOOKIPA Pharma: 4 Analysts Share Their Views
细分HOOKIPA Pharma：4位分析师分享了他们的观点
Across the recent three months, 4 analysts have shared their insights on HOOKIPA Pharma (NASDAQ:HOOK), expressing a variety of opinions spanning from bullish to bearish.
在最近三个月中，4位分析师分享了他们对HOOKIPA Pharma（纳斯达克股票代码：HOOK）的见解，表达了从看涨到看跌的各种观点。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表简要概述了分析师最近的评级，提供了对过去30天情绪变化的见解，并与前几个月进行了比较以获得整体视角。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $5.38, along with a high estimate of $6.50 and a low estimate of $5.00. This current average has decreased by 13.92% from the previous average price target of $6.25.
分析师提供了更深入的见解，确定了12个月的目标股价，平均目标价为5.38美元，最高估计为6.50美元，低估值为5.00美元。目前的平均价格较之前的平均目标价6.25美元下降了13.92％。
Analyzing Analyst Ratings: A...
分析分析...
登录免费看全文
登录/注册